What does this article add?
In our large-scale retrospective cohort study, we examined the effect of atorvastatin, as a lipophilic statin, on outcomes of patients with severe to critical form of COVID-19. In addition to decrease in mortality, we observed lower risk of need of invasive mechanical ventilation associated with atorvastatin administration and also shorter hospital length of stay in patients who received atorvastatin.